PROTEAN.BO(PROTEAN.BO)
PROTEAN.BO
No analyst ratings available
No analyst price targets available for PROTEAN.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $11.61B | $12.54B |
| Low | $11.37B | $12.04B |
| High | $11.85B | $13.05B |
| EBITDA Avg | $2.27B | $2.46B |
| Low | $2.23B | $2.36B |
| High | $2.32B | $2.56B |
| EBIT Avg | $1.90B | $2.05B |
| Low | $1.86B | $1.97B |
| High | $1.94B | $2.14B |
| Net Income Avg | $1.29B | $1.40B |
| Low | $1.26B | $1.25B |
| High | $1.33B | $1.54B |
| EPS Avg | $31.70 | $34.40 |
| Low | $30.86 | $30.62 |
| High | $32.56 | $37.89 |
| Analysts (Rev / EPS) | 1 / 1 | 3 / 3 |